US Patent Issued to HEALX on Oct. 20 for "Treatment of plexiform neurofibroma with nitroxoline" (British Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,135, issued on Oct. 20, was assigned to HEALX LTD (Cambridge, Great Britain).

"Treatment of plexiform neurofibroma with nitroxoline" was invented by David Brown (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising nitroxoline, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention of a plexiform neurofibroma."

The patent was filed on Nov. 18, 2022, under Application No. 18/710,477.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%...